Stocks · Health care · Biological Products, (No Diagnostic Substances)

Beam Therapeutics Inc.

BEAM Clue Score48
United States Fiscal year ends December CIK 0001745999 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
John M. Evans
16 Oct 2026
CEO
Sold after exercise
25,000
$23.98
$599.60K
John M. Evans
15 Oct 2026
CEO
Sold after exercise
25,000
$23.57
$589.15K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 50,000
History held since 11 Feb 2020